BancorpSouth’s AstraZeneca AZN Stock Holding History

BancorpSouth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$210K	Buy	+3,102	New	+$196K	0.02%	242
2016 Q4	–	Sell	-3,478	Closed	-$229K	–	232
2016 Q3	$229K	Buy	+3,478	New	+$227K	0.02%	208
2015 Q1	–	Sell	-4,256	Closed	-$300K	–	256
2014 Q4	$300K	Buy	4,256 +26	+0.6%	+$1.86K	0.03%	183
2014 Q3	$302K	Buy	4,230 +496	+13%	+$36.3K	0.03%	185
2014 Q2	$277K	Sell	3,734 -20,739	-85%	-$1.5M	0.03%	199
2014 Q1	$1.59M	Buy	24,473 +977	+4%	+$63.1K	0.17%	47
2013 Q4	$1.4M	Sell	23,496 -71	-0.3%	-$3.86K	0.15%	47
2013 Q3	$1.22M	Buy	23,567 +3,676	+18%	+$185K	0.14%	51
2013 Q2	$941K	Buy	+19,891	New	+$1.01M	0.11%	60

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BancorpSouth's AZN Position: Q3 2017 in Review

BancorpSouth opened a new position in AstraZeneca (AZN) in Q3 2017: 3,102 shares worth $210K. The stake represents 0.02% of the portfolio and ranks #242 among its holdings. This is a return to the name: BancorpSouth previously reported a position in AZN as recently as Q3 2016.

BancorpSouth first reported a position in AZN in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.59M in Q1 2014. 454 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

BancorpSouth held 3,102 shares of AstraZeneca worth $210K as of Q3 2017.
AstraZeneca was a new BancorpSouth position in Q3 2017.
AstraZeneca made up 0.02% of BancorpSouth's portfolio in Q3 2017, its #242 holding.
BancorpSouth first reported a position in AstraZeneca in Q2 2013 and has held it in 9 quarters since.
BancorpSouth's AstraZeneca position peaked at $1.59M in Q1 2014.
454 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.